Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia

NCT03965624 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Decision of sponsor: impossibility of contract with Takeda

Conditions

Immune Thrombocytopenia
Warm Autoimmune Hemolytic Anemia

Interventions

DRUG: Ninlaro

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]